STRO vs TWLO · rev $62.0M vs P/E 1087, rev $4.46B
Sutro Biopharma (STRO) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TWLO revenue for 2024-12-31 was $4.46B. Net income was -$109.4M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
STRO currently screens at market cap $470.8M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the STRO and TWLO stock pages for the full models.
Not investment advice.